203 related articles for article (PubMed ID: 34463908)
1. The emerging role of transcription factor FOXP3 in thyroid cancer.
Gong Z; Jia H; Xue L; Li D; Zeng X; Wei M; Liu Z; Tong MCF; Chen GG
Rev Endocr Metab Disord; 2022 Jun; 23(3):421-429. PubMed ID: 34463908
[TBL] [Abstract][Full Text] [Related]
2. Remodeling of the tumor microenvironment via disrupting Blimp1
Dixon ML; Luo L; Ghosh S; Grimes JM; Leavenworth JD; Leavenworth JW
Mol Cancer; 2021 Nov; 20(1):150. PubMed ID: 34798898
[TBL] [Abstract][Full Text] [Related]
3. Expression of indoleamine 2,3-dioxygenase and infiltration of FOXP3+ regulatory T cells are associated with aggressive features of papillary thyroid microcarcinoma.
Ryu HS; Park YS; Park HJ; Chung YR; Yom CK; Ahn SH; Park YJ; Park SH; Park SY
Thyroid; 2014 Aug; 24(8):1232-40. PubMed ID: 24742251
[TBL] [Abstract][Full Text] [Related]
4. PTEN-deficient prostate cancer is associated with an immunosuppressive tumor microenvironment mediated by increased expression of IDO1 and infiltrating FoxP3+ T regulatory cells.
Vidotto T; Saggioro FP; Jamaspishvili T; Chesca DL; Picanço de Albuquerque CG; Reis RB; Graham CH; Berman DM; Siemens DR; Squire JA; Koti M
Prostate; 2019 Jun; 79(9):969-979. PubMed ID: 30999388
[TBL] [Abstract][Full Text] [Related]
5. Regulatory (FoxP3
Koh J; Hur JY; Lee KY; Kim MS; Heo JY; Ku BM; Sun JM; Lee SH; Ahn JS; Park K; Ahn MJ
Sci Rep; 2020 Nov; 10(1):18994. PubMed ID: 33149213
[TBL] [Abstract][Full Text] [Related]
6. Control of regulatory T-cell differentiation and function by T-cell receptor signalling and Foxp3 transcription factor complexes.
Ono M
Immunology; 2020 May; 160(1):24-37. PubMed ID: 32022254
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional regulation of FOXP3 requires integrated activation of both promoter and CNS regions in tumor-induced CD8
Chakraborty S; Panda AK; Bose S; Roy D; Kajal K; Guha D; Sa G
Sci Rep; 2017 May; 7(1):1628. PubMed ID: 28487507
[TBL] [Abstract][Full Text] [Related]
8. Indoleamine 2,3-dioxygenase 1 (IDO1) is up-regulated in thyroid carcinoma and drives the development of an immunosuppressant tumor microenvironment.
Moretti S; Menicali E; Voce P; Morelli S; Cantarelli S; Sponziello M; Colella R; Fallarino F; Orabona C; Alunno A; de Biase D; Bini V; Mameli MG; Filetti S; Gerli R; Macchiarulo A; Melillo RM; Tallini G; Santoro M; Puccetti P; Avenia N; Puxeddu E
J Clin Endocrinol Metab; 2014 May; 99(5):E832-40. PubMed ID: 24517146
[TBL] [Abstract][Full Text] [Related]
9. Increased Expression of GARP in Papillary Thyroid Carcinoma.
Zhang X; Guo M; Yang J; Zheng Y; Xiao Y; Liu W; Ren F
Endocr Pathol; 2019 Mar; 30(1):1-7. PubMed ID: 30443770
[TBL] [Abstract][Full Text] [Related]
10. A Phenotypic Screening Approach Using Human Treg Cells Identified Regulators of Forkhead Box p3 Expression.
Ding M; Brengdahl J; Lindqvist M; Gehrmann U; Ericson E; von Berg S; Ripa L; Malhotra R
ACS Chem Biol; 2019 Mar; 14(3):543-553. PubMed ID: 30807094
[TBL] [Abstract][Full Text] [Related]
11. FOXP3/HAT1 Axis Controls Treg Infiltration in the Tumor Microenvironment by Inducing CCR4 Expression in Breast Cancer.
Sarkar T; Dhar S; Chakraborty D; Pati S; Bose S; Panda AK; Basak U; Chakraborty S; Mukherjee S; Guin A; Jana K; Sarkar DK; Sa G
Front Immunol; 2022; 13():740588. PubMed ID: 35222362
[TBL] [Abstract][Full Text] [Related]
12. Analysis of regulatory T cells frequency in peripheral blood and tumor tissues in papillary thyroid carcinoma with and without Hashimoto's thyroiditis.
Liu Y; Yun X; Gao M; Yu Y; Li X
Clin Transl Oncol; 2015 Apr; 17(4):274-80. PubMed ID: 25387566
[TBL] [Abstract][Full Text] [Related]
13. Alternative Splicing of
Joly AL; Seitz C; Liu S; Kuznetsov NV; Gertow K; Westerberg LS; Paulsson-Berne G; Hansson GK; Andersson J
Circ Res; 2018 May; 122(10):1385-1394. PubMed ID: 29618596
[TBL] [Abstract][Full Text] [Related]
14. Regulatory T Cells: the Many Faces of Foxp3.
Georgiev P; Charbonnier LM; Chatila TA
J Clin Immunol; 2019 Oct; 39(7):623-640. PubMed ID: 31478130
[TBL] [Abstract][Full Text] [Related]
15. Elevated expression of Foxp3 in tumor-infiltrating Treg cells suppresses T-cell proliferation and contributes to gastric cancer progression in a COX-2-dependent manner.
Yuan XL; Chen L; Li MX; Dong P; Xue J; Wang J; Zhang TT; Wang XA; Zhang FM; Ge HL; Shen LS; Xu D
Clin Immunol; 2010 Mar; 134(3):277-88. PubMed ID: 19900843
[TBL] [Abstract][Full Text] [Related]
16. Epigenetical Targeting of the FOXP3 Gene by S-Adenosylmethionine Diminishes the Suppressive Capacity of Regulatory T Cells Ex Vivo and Alters the Expression Profiles.
Sahin E; Sahin M
J Immunother; 2019 Jan; 42(1):11-22. PubMed ID: 30407230
[TBL] [Abstract][Full Text] [Related]
17. Post-Translational Regulations of Foxp3 in Treg Cells and Their Therapeutic Applications.
Dong Y; Yang C; Pan F
Front Immunol; 2021; 12():626172. PubMed ID: 33912156
[TBL] [Abstract][Full Text] [Related]
18. Prognostic potential of FOXP3 expression in non-small cell lung cancer cells combined with tumor-infiltrating regulatory T cells.
Tao H; Mimura Y; Aoe K; Kobayashi S; Yamamoto H; Matsuda E; Okabe K; Matsumoto T; Sugi K; Ueoka H
Lung Cancer; 2012 Jan; 75(1):95-101. PubMed ID: 21719142
[TBL] [Abstract][Full Text] [Related]
19. From stability to dynamics: understanding molecular mechanisms of regulatory T cells through Foxp3 transcriptional dynamics.
Bending D; Ono M
Clin Exp Immunol; 2019 Jul; 197(1):14-23. PubMed ID: 30076771
[TBL] [Abstract][Full Text] [Related]
20. Tumor-infiltrating lymphocytes, tumor characteristics, and recurrence in patients with early breast cancer.
Kim ST; Jeong H; Woo OH; Seo JH; Kim A; Lee ES; Shin SW; Kim YH; Kim JS; Park KH
Am J Clin Oncol; 2013 Jun; 36(3):224-31. PubMed ID: 22495453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
